以肝素钠为原料,经成盐、酯化、解聚和纯化得到依诺肝素钠。
Enoxaparin sodium was prepared from heparin sodium via salinization, esterification, depolymerization and purification.
本发明提供了一种治疗肝素相关性血小板减少症的药物组合,其主要成分包括可接受药物量的重组水蛭素及其医药上可接受的盐。
The invention provides a medicine composition for curing heparin-induced thrombocytopenia. The main components include Lepirudin and salt which can be accepted by the medicine.
应用推荐